Top Markets
Coin of the day
Rebus Holdings, Inc. Rebus Holdings, Inc.

Rebus Holdings, Inc.

RBSH
Rangering i aksjer #42217
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for... Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$3.21K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Rebus Holdings, Inc. (RBSH)

Kategori

Utbyttehistorikk for Rebus Holdings, Inc. (RBSH)
Rebus Holdings, Inc. (aksjesymbol: RBSH) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Rebus Holdings, Inc. (RBSH) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR